Literature DB >> 6743509

In vitro osteolytic activity of human myeloma plasma cells and the clinical evaluation of myeloma osteoclastic bone lesions.

J F Rossi, R Bataille.   

Abstract

Entities:  

Mesh：

Year:  1984        PMID： 6743509      PMCID： PMC1976933          DOI： 10.1038/bjc.1984.147

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  11 in total

1.  Controlled environment culture of bone marrow explants from human myeloma.

Authors:  S Gailani; W F McLimans; G R Mundy; A Nussbaum; O Roholt; R Zeigel
Journal:  Cancer Res       Date:  1976-04       Impact factor: 12.701

2.  Evidence for the secretion of an osteoclast stimulating factor in myeloma.

Authors:  G R Mundy; L G Raisz; R A Cooper; G P Schechter; S E Salmon
Journal:  N Engl J Med       Date:  1974-11-14       Impact factor: 91.245

3.  Bone-resorbing activity in supernatants from lymphoid cell lines.

Authors:  G R Mundy; R A Luben; L G Raisz; J J Oppenheim; D N Buell
Journal:  N Engl J Med       Date:  1974-04-18       Impact factor: 91.245

4.  Human bone marrow colony growth in agar-gel.

Authors:  B L Pike; W A Robinson
Journal:  J Cell Physiol       Date:  1970-08       Impact factor: 6.384

5.  Long-term effects of dichloromethylene diphosphonate (CI2MDP) on skeletal lesions in multiple myeloma.

Authors:  P D Delmas; S Charhon; M C Chapuy; E Vignon; D Briancon; C Edouard; P J Meunier
Journal:  Metab Bone Dis Relat Res       Date:  1982

6.  Localized and indolent myeloma.

Authors:  R Alexanian
Journal:  Blood       Date:  1980-09       Impact factor: 22.113

7.  Relation of osteoclast activating factor production to extent of bone disease in multiple myeloma.

Authors:  B G Durie; S E Salmon; G R Mundy
Journal:  Br J Haematol       Date:  1981-01       Impact factor: 6.998

8.  A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival.

Authors:  B G Durie; S E Salmon
Journal:  Cancer       Date:  1975-09       Impact factor: 6.860

9.  Clinical evaluation of myeloma osteoclastic bone lesions: II. Induced hypocalcemia test using salmon calcitonin.

Authors:  R Bataille; J Sany
Journal:  Metab Bone Dis Relat Res       Date:  1982

10.  Quantitative histology of myeloma-induced bone changes.

Authors:  A Valentin-Opran; S A Charhon; P J Meunier; C M Edouard; M E Arlot
Journal:  Br J Haematol       Date:  1982-12       Impact factor: 6.998
View more
  3 in total

1.  Recruitment of new osteoblasts and osteoclasts is the earliest critical event in the pathogenesis of human multiple myeloma.

Authors:  R Bataille; D Chappard; C Marcelli; P Dessauw; P Baldet; J Sany; C Alexandre
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

Review 2.  Osteosclerotic myeloma with polyneuropathy and hypocalcemia.

Authors:  C Ludescher; K Grünewald; F Fend; O Dietze; J Thaler; K W Schmid
Journal:  Blut       Date:  1989-04

3.  Importance of quantitative histology of bone changes in monoclonal gammopathy.

Authors:  R Bataille; D Chappard; C Alexandre; P Dessauw; J Sany
Journal:  Br J Cancer       Date:  1986-06       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.